Abstract: The present disclosure relates to recombinant polypeptides that have olivetolic acid cyclase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant polypeptides, nucleic acids, and/or recombinant host cells. The present disclosure also relates to uses of these recombinant polypeptides, nucleic acids encoding them, and recombinant host cells comprising them, in methods for the preparation of cannabinoids and cannabinoid precursors.
Type:
Application
Filed:
May 10, 2024
Publication date:
December 5, 2024
Applicants:
WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
Inventors:
Trish CHOUDHARY, Xueyang FENG, Thanh NGUYEN, Matthew WORKENTINE
Abstract: The present disclosure relates to recombinant polypeptides that have olivetolic acid cyclase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant polypeptides, nucleic acids, and/or recombinant host cells. The present disclosure also relates to uses of these recombinant polypeptides, nucleic acids encoding them, and recombinant host cells comprising them, in methods for the preparation of cannabinoids and cannabinoid precursors.
Type:
Grant
Filed:
June 20, 2023
Date of Patent:
June 25, 2024
Assignees:
WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
Inventors:
Trish Choudhary, Xueyang Feng, Thanh Nguyen, Matthew Workentine
Abstract: The present disclosure relates to recombinant polypeptides that have olivetolic acid cyclase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant polypeptides, nucleic acids, and/or recombinant host cells. The present disclosure also relates to uses of these recombinant polypeptides, nucleic acids encoding them, and recombinant host cells comprising them, in methods for the preparation of cannabinoids and cannabinoid precursors.
Type:
Application
Filed:
June 20, 2023
Publication date:
March 28, 2024
Applicants:
WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
Inventors:
Trish CHOUDHARY, Xueyang FENG, Thanh NGUYEN, Matthew WORKENTINE
Abstract: The present disclosure provides methods for making glycosylated cannabinoids including methods using recombinant host cells comprising a pathway capable of producing a cannabinoid and a heterologous nucleic acid that encodes a UDP-glycosyl transferase. The disclosure also provides compositions of recombinant host cells capable of producing glycosylated cannabinoids, and compositions and uses of the glycosylated cannabinoids.
Type:
Application
Filed:
May 3, 2023
Publication date:
October 26, 2023
Applicants:
WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
Abstract: The present disclosure provides recombinant host cells comprising a pathway capable of producing a cannabinoid and/or cannabinoid precursor, wherein the pathway comprises an enzyme AAE from a source organism other than Cannabis sativa, such as Humulus lupulus. The disclosure also provides methods of using the host cells to produce rare cannabinoids and/or rare cannabinoid precursors.
Type:
Application
Filed:
December 10, 2021
Publication date:
June 16, 2022
Applicants:
Willow Biosciences, Inc., Epimeron USA, Inc.